Antiphospholipid Syndrome in Pregnancy
A 31-year-old woman at 7 weeks of gestation has had three consecutive unexplained first-trimester miscarriages and one unprovoked deep vein thrombosis 2 years ago, after which warfarin was started. Lupus anticoagulant and anticardiolipin IgG were positive on two occasions 12 weeks apart, confirming antiphospholipid syndrome. She stopped warfarin 10 days ago when her pregnancy test became positive. What is the most appropriate antithrombotic regimen for this pregnancy?
- A.Rivaroxaban at standard treatment dosing
- B.Therapeutic-dose warfarin restarted immediately
- C.Low-dose aspirin used as the only agent
- D.Low-molecular-weight heparin plus low-dose aspirinCorrect
Explanation
A pregnant woman with antiphospholipid syndrome, prior thrombosis and recurrent pregnancy loss requires the combination of low-molecular-weight heparin and low-dose aspirin, started as early in pregnancy as possible and continued through delivery and for at least 6 weeks postpartum. Antiphospholipid antibodies promote thrombosis by activating endothelial cells, platelets and complement and by interfering with beta-2 glycoprotein I on trophoblast, producing both maternal thrombosis and placental insufficiency with recurrent loss. Heparin acts not only as an anticoagulant but also by inhibiting complement activation at the maternal-fetal interface, while aspirin improves placental perfusion; the combination roughly doubles live birth rates compared with aspirin alone. Because she has a prior thrombotic event she needs therapeutic rather than prophylactic dose heparin. Warfarin is contraindicated in the first trimester because it crosses the placenta and causes warfarin embryopathy with nasal hypoplasia and stippled epiphyses between 6 and 12 weeks of gestation, and it carries fetal bleeding risk later; it is switched back in only after delivery, where it is safe in breastfeeding. Aspirin alone is inadequate for a woman with established thrombosis. Direct oral anticoagulants such as rivaroxaban are contraindicated in pregnancy because of placental transfer and inadequate safety data, and they are also inferior to warfarin in triple-positive antiphospholipid syndrome outside pregnancy. Additional care includes serial growth ultrasounds and uterine artery Doppler for placental insufficiency, and vigilance for preeclampsia.
Why each option
- A.
- Direct oral anticoagulants cross the placenta, lack pregnancy safety data and perform poorly in antiphospholipid syndrome.
- B.
- Warfarin is teratogenic between 6 and 12 weeks of gestation and must be avoided in the first trimester.
- C.
- Aspirin alone is insufficient for a woman with a previous thrombotic event and recurrent losses.
- D.
- Correct. Heparin plus low-dose aspirin is standard for antiphospholipid syndrome in pregnancy and substantially improves live birth rates.
Reference: EULAR Recommendations for the Management of Antiphospholipid Syndrome in Adults, 2019; ACOG Practice Bulletin on Antiphospholipid Syndrome, 2022 reaffirmed
This is one of 3,009 questions in the MedBoardSA SMLE bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bank